CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 200 filers reported holding CHEMOCENTRYX INC in Q4 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $163,000 | +19.0% | 3,130 | -43.3% | 0.00% | – |
Q2 2022 | $137,000 | -35.4% | 5,520 | -15.9% | 0.00% | – |
Q1 2022 | $212,000 | -68.8% | 6,560 | -64.9% | 0.00% | -100.0% |
Q4 2021 | $680,000 | +623.4% | 18,677 | +242.0% | 0.00% | – |
Q3 2021 | $94,000 | +6.8% | 5,461 | -17.6% | 0.00% | – |
Q2 2021 | $88,000 | +95.6% | 6,625 | +667.7% | 0.00% | – |
Q1 2021 | $45,000 | -13.5% | 863 | +0.9% | 0.00% | – |
Q4 2020 | $52,000 | +940.0% | 855 | +860.7% | 0.00% | – |
Q3 2020 | $5,000 | -89.4% | 89 | -92.3% | 0.00% | – |
Q1 2020 | $47,000 | – | 1,161 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |